XXI

Photos: Compact Barbell System With Flat, Streamlined Profile Travels Easily and Stores Conveniently

...are shipped with a custom, zippered tote bag. For more information on The Burn Machine, log on at http://www.theburnmachine.com, or call Portfolio xxi at 586-447-2001. ...

XXI in Medical Technology

Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)

SOUTH SAN FRANCISCO, July 02, 2007 /PRNewswire/ -- Portola Pharmaceuticals, Inc. announced today that it will present clinical and preclinical data on its oral Factor Xa inhibitor and on its intravenous and oral ADP receptor antagonist at the XXI Congress of the International Society of Thrombosis...

Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis

SAN FRANCISCO, July 10, 2007 /PRNewswire/ -- Portola Pharmaceuticals, Inc. announced positive Phase II data on its lead compound, PRT054021, an oral Factor Xa inhibitor, today at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH) in Geneva, Switzerland. The EXPERT t...

Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis

HORSHAM, Pa.--(BUSINESS WIRE)--Jul 11, 2007 - Neose Technologies, Inc. (Nasdaq GM:NTEC) today announced that two poster presentations were presented with its collaborative partner, Novo Nordisk A/S, relating to GlycoPEGylated recombinant Factor VIIa at the XXIst Congress of the International Societ...

Video: The Arizona Heart Institute Announces the Largest Worldwide Experience with Endoluminal Grafting to Treat Thoracic Aortic Aneurysms and Related Pathologies

...pathologies: A single center experience International Society of Endovascular Specialists International Congress xxi Endovascular Interventions ...

Portola Pharmaceuticals Announces Positive Phase II Results for PRT054021 for Prevention of Venous Thromboembolism Following Total Knee Replacement Surgery

... Data to be Presented at the xxi Congress of the International Society on Thrombosis and Haemostasis SOUTH ...und into further clinical trials. Data from EXPERT will be presented at the xxi Congress of the International Society on Thrombosis and Haemostasis in Gene...

Othera Pharmaceuticals Announces Upcoming Presentation Based Upon Expanded Understanding of Lead Compound Mechanism of Action

...ell as studies on novel, orally-available analog compounds under development for non-ophthalmic indications. Dr. Mousa's talk will be presented at the xxi International Society on Thrombosis and Haemostasis (ISTH) Congress in Geneva, Switzerland on July 9, 2007. The ISTH holds its congress every other ye...

Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery

... GENEVA--(BUSINESS WIRE)--Jul 8, 2007 - Late-breaking Phase III clinical trial data presented today at the xxi International Society on Thrombosis and Haemostasis (ISTH) Congress demonstrate that once-daily rivaroxaban achieved superior efficacy in the preventi...

Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery

...Compared with Enoxaparin with Similarly Low Bleeding Rates GENEVA, July 8, 2007 - Late-breaking Phase III clinical trial data presented today at the xxi International Society on Thrombosis and Haemostasis (ISTH) Congress demonstrate that once-daily rivaroxaban (Xarelto®) achieved superior efficacy ...

XXI in Biological News

IRB Barcelona to coordinate two European projects on biomedicine

...r professor at the University of Barcelona, will coordinate a pioneering project to fight against diabetes, a disease described as the epidemic of the xxi century. The MITIN Project is innovative because it will be the first time that bioinformatics is applied to obtain information about complex diseases...

CO2 increase in the atmosphere augments tolerance of barley to salinity

...ction in its growth. The Intergovernmental Panel on Climate Change (IPCC) predicts that the CO 2 concentration in the atmosphere at the end of the xxi century will double current levels. An increase contributed to by human activity through the combustion of fossil fuels and the destruction of forests...